Three Peaks Capital Management’s ResMed RMD Stock Holding History

Three Peaks Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-22,112	Closed	-$2.52M	–	113
2018 Q4	$2.52M	Sell	22,112 -9,294	-30%	-$996K	0.79%	68
2018 Q3	$3.62M	Sell	31,406 -4,141	-12%	-$454K	0.74%	50
2018 Q2	$3.68M	Buy	+35,547	New	+$3.6M	0.74%	67

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Three Peaks Capital Management's RMD Position: Q1 2019 in Review

Three Peaks Capital Management sold out of ResMed (RMD) in Q1 2019, closing a stake of 22,112 shares — an estimated $2.52M sold.

Three Peaks Capital Management first reported a position in RMD in Q2 2018 and held it in 3 quarters. The position peaked at $3.68M in Q2 2018. 477 funds tracked by Wall St. Rank hold RMD as of Q1 2019.

Three Peaks Capital Management reported no remaining ResMed position as of Q1 2019 after selling out during the quarter.
Three Peaks Capital Management sold 22,112 ResMed shares in Q1 2019, an estimated $2.52M.
Three Peaks Capital Management first reported a position in ResMed in Q2 2018 and held it in 3 quarters.
Three Peaks Capital Management's ResMed position peaked at $3.68M in Q2 2018.
477 funds tracked by Wall St. Rank held ResMed as of Q1 2019.

Based on Three Peaks Capital Management's 13F filing for Q1 2019, filed 25 Apr 2019.